Join
Live feed
·
INSIDERFilingvia Quantisnow
Seres Therapeutics Inc. logo

Chief Legal Officer and EVP Desrosier Thomas converted options into 244 shares and sold $575 worth of shares (79 units at $7.28), increasing direct ownership by 2% to 7,287 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
MCRB· Seres Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MCRB (Seres Therapeutics Inc.) and more on Quantisnow.